NMDA Antagonists and Neuropathic Pain - Multiple Drug Targets and Multiple Uses

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|11|23|2977-2994

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.11, Iss.23, 2005-09, pp. : 2977-2994

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

NMDA receptors as targets for drug action in neuropathic pain

By Parsons C.G.  

European Journal of Pharmacology, Vol. 429, Iss. 1, 2001-10 ,pp. : 71-78

Elsevier

Access to resources Recommend Favorite

Managing Neuropathic Pain in Multiple Sclerosis: Pharmacological Interventions

By  

Medicinal Chemistry, Vol. 14, Iss. 2, 2018-02 ,pp. : 106-119

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetic and pharmacodynamic considerations for NMDA receptor antagonists in the treatment of chronic neuropathic pain

By Niesters Marieke   Dahan Albert  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 8, Iss. 11, 2012-11 ,pp. : 1409-1417

Informa Healthcare

Access to resources Recommend Favorite

Chronic administration of amitriptyline and caffeine in a rat model of neuropathic pain: multiple interactions

By Esser M.J.   Chase T.   Allen G.V.   Sawynok J.  

European Journal of Pharmacology, Vol. 430, Iss. 2, 2001-11 ,pp. : 211-218

Elsevier

Access to resources Recommend Favorite

Sativex®: clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain

By Barnes Michael Philip  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 5, 2006-04 ,pp. : 607-615

Informa Healthcare

Access to resources Recommend Favorite